Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.97 USD | -6.07% | -6.07% | +12.69% |
Apr. 24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
Apr. 24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.06B |
---|---|---|---|---|---|
Net income 2024 * | -195M | Net income 2025 * | -209M | EV / Sales 2024 * | - |
Net cash position 2024 * | 92.93M | Net cash position 2025 * | 93.52M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.25
x | P/E ratio 2025 * |
-5.51
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.4% |
Latest transcript on Centessa Pharmaceuticals plc
1 day | -5.03% | ||
1 week | -4.33% | ||
Current month | -1.09% | ||
1 month | -18.74% | ||
3 months | -5.62% | ||
6 months | +45.89% | ||
Current year | +13.82% |
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 20-12-31 |
Director of Finance/CFO | 53 | 21-02-28 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 21-02-22 | |
Chairman | 54 | 20-10-31 | |
Brett Zbar
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 8.97 | -6.07% | 68 436 |
24-05-09 | 9.55 | +0.74% | 66,810 |
24-05-08 | 9.48 | -1.96% | 74,605 |
24-05-07 | 9.67 | +4.54% | 161,793 |
24-05-06 | 9.25 | -2.32% | 74,239 |
Delayed Quote Nasdaq, May 10, 2024 at 12:23 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.82% | 1.06B | |
+18.45% | 47.02B | |
+48.77% | 41.86B | |
+0.31% | 41.76B | |
-4.27% | 28.8B | |
+11.63% | 26.05B | |
-22.14% | 19.15B | |
+4.35% | 12.55B | |
+29.66% | 12.34B | |
-4.08% | 11.82B |
- Stock Market
- Equities
- CNTA Stock